68Ga-DOTA.SA.FAPI作为复发性和转移性肾上腺皮质癌的潜在无创诊断探针:与18F-FDG的头对头比较
该研究评估含方酸FAPI衍生物DOTA.SA.FAPI在2例经组织病理学证实的转移性和复发性肾上腺皮质癌(ACC)患者中的诊断价值,两例患者均接受18F-FDG和68Ga-FAPI PET/CT扫描进行对比分析。68Ga-DOTA.SA.FAPI在ACC诊断中表现优异,与18F-FDG相似。
要点
- 在2例转移性和复发性肾上腺皮质癌患者中评估68Ga-DOTA.SA.FAPI PET/CT的诊断价值
- 68Ga-DOTA.SA.FAPI在ACC诊断中表现优异,与18F-FDG相似
- 两例患者均经组织病理学证实为转移性和复发性ACC
核心结论
- 68Ga-DOTA.SA.FAPI在肾上腺皮质癌诊断中表现优异,与18F-FDG相似。
研究设计与样本
- 在2例经组织病理学证实的转移性和复发性肾上腺皮质癌患者中评估68Ga-DOTA.SA.FAPI的诊断价值。
- 两例患者均接受18F-FDG和68Ga-FAPI PET/CT扫描进行对比分析。
主要发现
- 68Ga-DOTA.SA.FAPI在2例转移性和复发性肾上腺皮质癌患者中表现与18F-FDG相似。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Metastatic or recurrent adrenocortical carcinoma (ACC) is a potentially fatal malignancy, which poses major challenges in disease management owing to lack of effective systemic therapies. The drastically reduced survival rates require prompt identification of selective molecules for development of targeted therapeutics. We evaluated the squaric acid containing FAPI derivative, DOTA.SA.FAPI (FAPI), as a potential diagnostic probe in 2 cases of histopathologically proven metastatic and recurrent ACC. Both patients underwent 18 F-FDG and 68 Ga-FAPI PET/CT scans for comparative analysis. 68 Ga-DOTA.SA.FAPI emerged as an excellent diagnostic agent for ACC and performed similar to 18 F-FDG.
引用
- Chopra S, Walia R, Mathur Y, et al. 68 Ga-DOTA.SA.FAPI as a Potential, Noninvasive Diagnostic Probe for Recurrent and Metastatic Adrenocortical Carcinoma : A Head-to-Head Comparison With 18F-FDG. Clin Nucl Med. 2023. PMID: 36727882. doi:10.1097/RLU.0000000000004563
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。